United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2018

March 2018 | 96 pages | ID: UD884131053QEN
QYResearch

Abstracts

In this report, the United States 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in these regions, from 2013 to 2025 (forecast).

United States 23-Valent Pneumococcal Polysaccharide Vaccine market competition by top manufacturers/players, with 23-Valent Pneumococcal Polysaccharide Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• MSD
• Sanofipasteur
• CDIBP

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Single Dose Vial
• Pre-Filled Syringe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Children (2-10 Age)
• Adult (10-64 Age)
• Geriatric (More Than 65 Age)

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2018

1 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERVIEW

1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine by Product Category
  1.2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Single Dose Vial
  1.2.4 Pre-Filled Syringe
1.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application/End Users
  1.3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Children (2-10 Age)
  1.3.3 Adult (10-64 Age)
  1.3.4 Geriatric (More Than 65 Age)
1.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region
  1.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
  1.4.3 Southwest 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
  1.4.5 New England 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
  1.4.6 The South 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
  1.4.7 The Midwest 23-Valent Pneumococcal Polysaccharide Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2013-2025)
  1.5.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2013-2025)

2 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
  2.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
  2.4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Region (2013-2018)

4 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2013-2018)
4.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 MSD
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Sanofipasteur
  6.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CDIBP
  6.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview

7 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MANUFACTURING COST ANALYSIS

7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (K Units) by Type (2013-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Single Dose Vial Product Picture
Figure Pre-Filled Syringe Product Picture
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2017
Figure Children (2-10 Age) Examples
Table Key Downstream Customer in Children (2-10 Age)
Figure Adult (10-64 Age) Examples
Table Key Downstream Customer in Adult (10-64 Age)
Figure Geriatric (More Than 65 Age) Examples
Table Key Downstream Customer in Geriatric (More Than 65 Age)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) and Growth Rate (2013-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players/Suppliers
Figure 2017 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Players/Suppliers
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Players/Suppliers
Table United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Players/Suppliers
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers 23-Valent Pneumococcal Polysaccharide Vaccine Product Category
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Region (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Region (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Region (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2017
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Region (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2017
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Region (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Type (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2017
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2013-2018)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2017
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) by Types (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units) by Application (2013-2018)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2017
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2013-2018)
Table MSD Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in United States (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in United States (2013-2018)
Table Sanofipasteur Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in United States (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in United States (2013-2018)
Table CDIBP Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in United States (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Players/Suppliers in 2017
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Unit) Trend Forecast (2018-2025)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Type in 2025
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Application in 2025
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources